Corporate Headquarters Corporate Public Relations Transfer Agent Annual Meeting SEC Form 10-K Stock Symbol Independent Accountants Firms Following and/or Regularly Reporting on  Edwards Lifesciences Information on the Internet Investor Information Edwards Lifesciences Corporation One Edwards Way Irvine, CA 92614 (949) 250-2500 (800) 4-A-HEART www.edwards.com Members of the news media should call: (949) 250-5070 Correspondence about share ownership, account status, the transfer or exchange of shares, lost stock certificates, duplicate mailings or change of address may be directed to: EquiServe Trust Company, N.A. P.O. Box 43023 Providence, RI 02940-3069 (800) 756-8200 Hearing impaired # TDD: (800) 952-9245 www.equiserve.com The Annual Meeting of Stockholders will be held on  May 14, 2003 at 10:00 a.m. Pacific Time at the offices of Edwards Lifesciences Corporation, One Edwards Way,  Irvine, California 92614. A copy of Edwards Lifesciences’ annual report to the  Securities and Exchange Commission on Form 10-K is available without charge upon request to our Investor  Relations department. It is also available on our Web site  at www.edwards.com. Edwards Lifesciences’ stock is traded on The New York Stock Exchange (NYSE) under the symbol EW. PricewaterhouseCoopers LLP Orange County, CA Adams, Harkness & Hill A.G. Edwards & Sons, Inc. Bear, Stearns & Co. Inc. Fahnestock & Co. Goldman Sachs J.P. Morgan Chase & Co. Lazard Freres & Co. L.L.C. Leerink Swann & Co. Merrill Lynch UBS Warburg U.S. Bancorp Piper Jaffray Wedbush Morgan Securities William Blair & Company, L.L.C. Edwards Lifesciences’ Web site at www.edwards.com  provides access to a wide range of information for our customers, patients and shareholders. Persons interested in investing in Edwards Lifesciences are invited to visit the “Investor Information” section of our Web site to access our press releases, SEC filings and other company information. Edwards Lifesciences is an affirmative action, equal opportunity employer. Shareholders, securities analysts and investors seeking additional information about Edwards Lifesciences should contact: David K. Erickson Vice President, Investor Relations  (949) 250-2806 Phone (949) 250-2248 Fax investor_relations@edwards.com  S76 Edwards Lifesciences Corporation CORPORATE INFORMATION